首页|期刊导航|Traditional Medicine Research|Integrated serum pharmacochemistry and network pharmacology validate Qiangli Dingxuan Tablets ameliorates metabolic hypertension via TLR4/MyD88/NF-κB pathway
Integrated serum pharmacochemistry and network pharmacology validate Qiangli Dingxuan Tablets ameliorates metabolic hypertension via TLR4/MyD88/NF-κB pathway
Jia-Yue Zhu Ying-Jie Dong Ya-Wen Sun Min-Qiu Lin Fan Liu Jie Su Gui-Yuan Lv Su-Hong Chen
Traditional Medicine Research2026，Vol.11Issue(8)：P.1-14,14.
Traditional Medicine Research2026，Vol.11Issue(8)：P.1-14,14.DOI:10.53388/TMR20250306004
Integrated serum pharmacochemistry and network pharmacology validate Qiangli Dingxuan Tablets ameliorates metabolic hypertension via TLR4/MyD88/NF-κB pathway
摘要
关键词
metabolic hypertension/Modified Qiangli Dingxuan Tablets/TLR4/MyD88/NF-κB signaling pathway/serum-absorbed components/herbal medicine分类
医药卫生引用本文复制引用
Jia-Yue Zhu,Ying-Jie Dong,Ya-Wen Sun,Min-Qiu Lin,Fan Liu,Jie Su,Gui-Yuan Lv,Su-Hong Chen..Integrated serum pharmacochemistry and network pharmacology validate Qiangli Dingxuan Tablets ameliorates metabolic hypertension via TLR4/MyD88/NF-κB pathway[J].Traditional Medicine Research,2026,11(8):P.1-14,14.基金项目
supported by Natural science foundation of Zhejiang province(No.ZCLMS25H2801 to Ying-Jie Dong) （No.ZCLMS25H2801 to Ying-Jie Dong）
Zhejiang Provincial"Vanguard"and"Leading Goose"R&D Tackling Program(No.2025C02183 to Su-Hong Chen) （No.2025C02183 to Su-Hong Chen）
National Natural Science Foundation of China(No.82274134 to Su-Hong Chen and No.82404900 to Ying-Jie Dong) （No.82274134 to Su-Hong Chen and No.82404900 to Ying-Jie Dong）
the Key Laboratory of Zhejiang Province(No.2012E10002 to Gui-Yuan Lv). （No.2012E10002 to Gui-Yuan Lv）
